Komori
Daishin Chemical (4629) · FactIncrease in full-year R&D expenses

Recording ¥18 million in research and development expenses

First written in FY2019-Q1. . Latest entry: FY2026.

25entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2019-Q1 – FY20262018: 220182019: 420192020: 420202021: 320212022: 420222023: 320232024: 320242025: 120252026: 12026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

90 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Increase in full-year R&D expensesAnnual report

    「Total R&D expenses incurred during the consolidated fiscal year were ¥99 million.」

    Full-year R&D expenses were ¥99 million, up from ¥94 million in the previous fiscal year. Development of environmentally friendly products, solvents derived from renewable energy, and paint strippers, among other products, continued.
  2. FY2026-H1Interim R&D expenses: ¥44 millionAnnual report

    「Total R&D expenses for the current interim consolidated period were ¥44 million.」

    R&D expenses were ¥44 million, down from ¥47 million in the same period of the previous year.
  3. FY2025-H1Interim R&D expenses: ¥47 millionAnnual report

    「Total R&D expenses for the consolidated interim accounting period were ¥47 million.」

    The company disclosed total R&D expenses of ¥47 million for the consolidated interim accounting period.
  4. FY2024Lower full-year R&D expensesAnnual report

    「Total R&D expenses incurred during the consolidated fiscal year were ¥94 million.」

    Full-year R&D expenses were ¥94 million, down from ¥117 million in the previous fiscal year. Development of environmentally friendly products, solvents derived from renewable energy, and paint strippers, among other products, continued.
  5. FY2024-Q3Disclosure of a ¥71 million increase in third-quarter R&D expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter increased by ¥71 million.」

    For R&D expenses for the nine months ended the third quarter, the company disclosed an increase of ¥71 million, as stated in the body of the report.
  6. FY2024-Q1First-quarter R&D expenses: ¥23 millionAnnual report

    「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥23 million.」

    The company disclosed total R&D expenses of ¥23 million for the three months ended the first quarter.
  7. FY2023Increase in full-year R&D expensesAnnual report

    「Total R&D expenses incurred during the consolidated fiscal year were ¥117 million.」

    Full-year R&D expenses were ¥117 million, up from ¥94 million in the previous fiscal year. The company also described its development of environmentally friendly products, solvents derived from renewable energy, and paint strippers, among other products.
  8. FY2023-Q3Third-quarter R&D expenses: ¥78 millionAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥78 million.」

    The company disclosed total R&D expenses of ¥78 million for the nine months ended the third quarter.
  9. FY2023-Q2Second-quarter R&D expenses: ¥52 millionAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥52 million.」

    The company disclosed total R&D expenses of ¥52 million for the six months ended the second quarter.
  10. FY2023-Q1First-quarter R&D expenses: ¥26 millionAnnual report

    「Total R&D expenses for the three months ended the first quarter were ¥26 million.」

    The company disclosed total R&D expenses of ¥26 million for the three months ended the first quarter.
  11. FY2022Lower full-year R&D expensesAnnual report

    「Total research and development expenses incurred by the Company during the current fiscal year were ¥94 million.」

    Full-year R&D expenses were ¥94 million, down from ¥96 million in the previous fiscal year.
  12. FY2022-Q3Third-quarter R&D expenses: ¥70 millionAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥70 million.」

    The company disclosed total R&D expenses of ¥70 million for the nine months ended the third quarter.
  13. FY2022-Q2Second-quarter research and development expenses of ¥47 millionAnnual report

    「Total research and development expenses for the cumulative second quarter of the current fiscal year were ¥47 million.」

    The Company discloses total research and development expenses of ¥47 million for the cumulative second quarter.
  14. FY2021Increase in full-year R&D expensesAnnual report

    「Total research and development expenses incurred by the Company during the current fiscal year were ¥96 million.」

    Full-year research and development expenses were ¥96 million, up from ¥94 million in the previous fiscal year.
  15. FY2021-Q3Third-quarter research and development expenses of ¥62 millionAnnual report

    「Total research and development expenses for the cumulative third quarter of the current fiscal year were ¥62 million.」

    The Company discloses total research and development expenses of ¥62 million for the cumulative third quarter.
  16. FY2021-Q2Second-quarter research and development expenses of ¥41 millionAnnual report

    「Total research and development expenses for the cumulative second quarter of the current fiscal year were ¥41 million.」

    The Company discloses total research and development expenses of ¥41 million for the cumulative second quarter.
  17. FY2021-Q1First-quarter research and development expenses of ¥21 millionAnnual report

    「Total research and development expenses for the cumulative first quarter of the current fiscal year were ¥21 million.」

    The Company discloses total research and development expenses of ¥21 million for the cumulative first quarter.
  18. FY2020Increase in full-year R&D expensesAnnual report

    「Total research and development expenses incurred by the Company during the current fiscal year were ¥94 million.」

    Full-year research and development expenses were ¥94 million, up from ¥78 million in the previous fiscal year.
  19. FY2020-Q3Cumulative R&D Expenses IncreasedAnnual report

    「Total research and development expenses for the cumulative third quarter of the current fiscal year were ¥61 million.」

    The Company discloses total research and development expenses of ¥61 million for the cumulative third quarter, an increase from ¥40 million in the cumulative second quarter.
  20. FY2020-Q2Cumulative R&D Expenses IncreasedAnnual report

    「Total research and development expenses for the cumulative second quarter of the current fiscal year were ¥40 million.」

    The Company discloses total research and development expenses of ¥40 million for the cumulative second quarter, an increase from ¥20 million in the first quarter.
  21. FY2020-Q1Cumulative recognition of research and development expensesAnnual report

    「Total research and development expenses for the cumulative first quarter of the current fiscal year were ¥20 million.」

    The Company discloses total research and development expenses of ¥20 million for the cumulative first quarter.
  22. FY2019Full-Year R&D Expense DisclosureAnnual report

    「Total research and development expenses incurred by the Company during the current fiscal year were ¥78 million.」

    The Company discloses full-year research and development expenses of ¥78 million.
  23. FY2019-Q3Cumulative R&D Expenses IncreasedAnnual report

    「Total research and development expenses for the cumulative third quarter of the current fiscal year were ¥55 million.」

    The Company discloses total research and development expenses of ¥55 million for the cumulative third quarter, an increase from ¥36 million in the cumulative second quarter.
  24. FY2019-Q2Cumulative R&D Expenses IncreasedAnnual report

    「Total research and development expenses for the cumulative second quarter of the current fiscal year were ¥36 million.」

    The Company discloses total research and development expenses of ¥36 million for the cumulative second quarter, an increase from ¥18 million in the first quarter.
  25. FY2019-Q1First statedAnnual report

    「Total research and development expenses for the cumulative first quarter of the current fiscal year were ¥18 million.」

    The Company discloses total research and development expenses of ¥18 million for the cumulative first quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daishin Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recording ¥18 million in research and development expenses | DAISHIN CHEMICAL CO.,LTD. (4629) | Komori